Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 7/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31482259 | 1.00 | ADRA1A (0.46) | ADRA1AALDH1A1LMNAKDM4EBCHE | |
| SCHEMBL31482170 | 0.89 | ADRA2C (0.43) | ADRA1AALDH1A1LMNAKDM4EBCHE | |
| SCHEMBL31482143 | 0.85 | KMT2A (0.45) | ADRA1AALDH1A1LMNABCHEKMT2A | |
| SCHEMBL31482209 | 0.85 | ADRA1A (0.41) | ADRA1AALDH1A1LMNABCHEKMT2A | |
| SCHEMBL31482174 | 0.82 | ADRA1A (0.40) | ADRA1AALDH1A1KMT2A | |
| SCHEMBL31482083 | 0.81 | ADRA1A (0.43) | ADRA1AALDH1A1LMNAKMT2A | |
| SCHEMBL31482210 | 0.81 | ALDH1A1 (0.38) | ADRA1AALDH1A1KMT2A | |
| SCHEMBL31482193 | 0.71 | BCHE (0.41) | ADRA1ALMNABCHEKMT2A | |
| SCHEMBL31482182 | 0.71 | ADRA1A (0.49) | ADRA1A | |
| SCHEMBL31482153 | 0.70 | KDM4E (0.44) | ALDH1A1KDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025068514-A1 | SUBSTITUTED HETEROCYCLIC CARBOXAMINDES AND USE THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 2025-04-03 | — | — | WO | disclosed |